1H-thieno[2,3-c]pyrazole derivatives useful as kinase inhibitors

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8481584
APP PUB NO 20120165311A1
SERIAL NO

13404697

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Thieno[2,3-c]pyrazole derivatives of formula (I) and pharmaceutically acceptable salts thereof, as defined in the specification, process for their preparation and pharmaceutical compositions comprising them are disclosed; the compounds of the invention may be useful, in therapy, in the treatment of diseases associated with a disregulated protein kinase activity, like cancer.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
NERVIANO MEDICAL SCIENCES S R L20014 NERVIANO (MI)

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bindi, Simona Milan, IT 15 22
Fancelli, Daniele Milan, IT 43 288
Tesei, Dania Ancona, IT 4 31
Varasi, Mario Milan, IT 86 1096
Vianello, Paola Milan, IT 29 117
Vioglio, Sergio Cusano Milanino, IT 10 62

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jan 9, 2025
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00